BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, Liang X, Lian Q, Tse HF. Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration. Expert Rev Cardiovasc Ther 2013;11:505-17. [PMID: 23570363 DOI: 10.1586/erc.13.5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Ibáñez-fonseca A, Rico A, Preciado S, González-pérez F, Muntión S, García-briñón J, García-macías M, Rodríguez-cabello JC, Pericacho M, Alonso M, Sánchez-guijo F. Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia. Front Bioeng Biotechnol 2022;10:918602. [DOI: 10.3389/fbioe.2022.918602] [Reference Citation Analysis]
2 Dang Le Q, Rodprasert W, Kuncorojakti S, Pavasant P, Osathanon T, Sawangmake C. In vitro generation of transplantable insulin-producing cells from canine adipose-derived mesenchymal stem cells. Sci Rep 2022;12:9127. [PMID: 35650303 DOI: 10.1038/s41598-022-13114-3] [Reference Citation Analysis]
3 Tan L, Liu X, Dou H, Hou Y. Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment — specific factors involved in the regulation of MSC plasticity. Genes & Diseases 2022;9:296-309. [DOI: 10.1016/j.gendis.2020.10.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Hu JL, Kim BJ, Yu NH, Kwon ST. Impact of Injection Frequency of Adipose-Derived Stem Cells on Allogeneic Skin Graft Survival Outcomes in Mice. Cell Transplant 2021;30:9636897211041966. [PMID: 34538121 DOI: 10.1177/09636897211041966] [Reference Citation Analysis]
5 Shrestha M, Nguyen TT, Park J, Choi JU, Yook S, Jeong JH. Immunomodulation effect of mesenchymal stem cells in islet transplantation. Biomed Pharmacother 2021;142:112042. [PMID: 34403963 DOI: 10.1016/j.biopha.2021.112042] [Reference Citation Analysis]
6 Sato M, Inohaya A, Yasuda E, Mogami H, Chigusa Y, Kawasaki K, Kawamura Y, Ueda Y, Takai H, Mandai M, Kondoh E. Three-dimensional human placenta-like bud synthesized from induced pluripotent stem cells. Sci Rep 2021;11:14167. [PMID: 34239021 DOI: 10.1038/s41598-021-93766-9] [Reference Citation Analysis]
7 Chen Y, Yan G, Ma Y, Zhong M, Yang Y, Guo J, Wang C, Han W, Zhang L, Xu S, Huang J, Dai H, Qi Z. Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1/IRF3-regulated-IFN-γ production. Immunol Lett 2021;238:21-8. [PMID: 34228988 DOI: 10.1016/j.imlet.2021.06.007] [Reference Citation Analysis]
8 Horiguchi M, Hata S, Tsurudome Y, Ushijima K. Characterizing the degeneration of nuclear membrane and mitochondria of adipose-derived mesenchymal stem cells from patients with type II diabetes. J Cell Mol Med 2021;25:4298-306. [PMID: 33759360 DOI: 10.1111/jcmm.16484] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Park HS, Chugh RM, Elsharoud A, Ulin M, Esfandyari S, Aboalsoud A, Bakir L, Al-Hendy A. Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model. Cell Transplant 2021;30:963689720988502. [PMID: 33593078 DOI: 10.1177/0963689720988502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rahbarghazi A, Siahkouhian M, Rahbarghazi R, Ahmadi M, Bolboli L, Keyhanmanesh R, Mahdipour M, Rajabi H. Role of melatonin in the angiogenesis potential; highlights on the cardiovascular disease. J Inflamm (Lond) 2021;18:4. [PMID: 33531055 DOI: 10.1186/s12950-021-00269-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nuge T, Liu Z, Liu X, Ang BC, Andriyana A, Metselaar HSC, Hoque ME. Recent Advances in Scaffolding from Natural-Based Polymers for Volumetric Muscle Injury. Molecules 2021;26:699. [PMID: 33572728 DOI: 10.3390/molecules26030699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
12 Zhao L, Hu C, Han F, Chen D, Ma Y, Wang J, Chen J. Cellular senescence, a novel therapeutic target for mesenchymal stem cells in acute kidney injury. J Cell Mol Med 2021;25:629-38. [DOI: 10.1111/jcmm.16163] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Juárez-Navarro KJ, Padilla-Camberos E, Díaz NF, Miranda-Altamirano A, Díaz-Martínez NE. Human Mesenchymal Stem Cells: The Present Alternative for High-Incidence Diseases, Even SARS-Cov-2. Stem Cells Int 2020;2020:8892189. [PMID: 33414832 DOI: 10.1155/2020/8892189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 Liu Y, Fang J. Mesenchymal Stem Cells as Therapeutic Agents and Novel Carriers for the Delivery of Candidate Genes in Acute Kidney Injury. Stem Cells Int 2020;2020:8875554. [PMID: 33381189 DOI: 10.1155/2020/8875554] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Beldi G, Bahiraii S, Lezin C, Nouri Barkestani M, Abdelgawad ME, Uzan G, Naserian S. TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties. Front Cell Dev Biol 2020;8:596831. [PMID: 33344453 DOI: 10.3389/fcell.2020.596831] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
16 Bagheri HS, Bani F, Tasoglu S, Zarebkohan A, Rahbarghazi R, Sokullu E. Mitochondrial donation in translational medicine; from imagination to reality. J Transl Med 2020;18:367. [PMID: 32977804 DOI: 10.1186/s12967-020-02529-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Choi A, Park SE, Jeong JB, Choi SJ, Oh SY, Ryu GH, Lee J, Jeon HB, Chang JW. Anti-Fibrotic Effect of Human Wharton's Jelly-Derived Mesenchymal Stem Cells on Skeletal Muscle Cells, Mediated by Secretion of MMP-1. Int J Mol Sci 2020;21:E6269. [PMID: 32872523 DOI: 10.3390/ijms21176269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Han D, Zheng X, Wang X, Jin T, Cui L, Chen Z. Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases. Stem Cells Int 2020;2020:8838046. [PMID: 32724315 DOI: 10.1155/2020/8838046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
19 Wang F, Pan S, Yao G, Zhang D, Wei X, Jiang S, Guo Y, Yu L. TIPE2 Improves the immune tolerance of human amniotic mesenchymal stem cells. All Life 2020;13:233-43. [DOI: 10.1080/26895293.2020.1757517] [Reference Citation Analysis]
20 Freitas GP, Lopes HB, Souza ATP, Oliveira PGFP, Almeida ALG, Souza LEB, Coelho PG, Beloti MM, Rosa AL. Cell Therapy: Effect of Locally Injected Mesenchymal Stromal Cells Derived from Bone Marrow or Adipose Tissue on Bone Regeneration of Rat Calvarial Defects. Sci Rep 2019;9:13476. [PMID: 31530883 DOI: 10.1038/s41598-019-50067-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
21 Wu Y, Yang J, Ai Z, Yu M, Li J, Li S. Identification of key genes and transcription factors in aging mesenchymal stem cells by DNA microarray data. Gene. 2019;692:79-87. [PMID: 30641220 DOI: 10.1016/j.gene.2018.12.063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wang D, Sun YQ, Gao WX, Fan XL, Shi JB, Fu QL. An in Vitro and in Vivo Study of the Effect of Dexamethasone on Immunoinhibitory Function of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.Cell Transplant. 2018;27:1340-1351. [PMID: 30056763 DOI: 10.1177/0963689718780194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
23 Zhu M, He X, Wang XH, Qiu W, Xing W, Guo W, An TC, Ao LQ, Hu XT, Li Z, Liu XP, Xiao N, Yu J, Huang H, Xu X. Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications. Diabetologia 2017;60:1822-33. [PMID: 28577176 DOI: 10.1007/s00125-017-4316-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
24 Gaafar T, Attia W, Mahmoud S, Sabry D, Aziz OA, Rasheed D, Hamza H. Cardioprotective Effects of Wharton Jelly Derived Mesenchymal Stem Cell Transplantation in a Rodent Model of Myocardial Injury. Int J Stem Cells 2017;10:48-59. [PMID: 28446005 DOI: 10.15283/ijsc16063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang Y, Chiu S, Liang X, Chai YH, Qin Y, Wang J, Li X, Qiu B, Tergaonkar V, Tse HF, Lian Q. Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection. Exp Cell Res 2017;356:74-84. [PMID: 28412246 DOI: 10.1016/j.yexcr.2017.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
26 Ding S, Kingshott P, Thissen H, Pera M, Wang P. Modulation of human mesenchymal and pluripotent stem cell behavior using biophysical and biochemical cues: A review: Modulation of Human Stem Cell Behavior: A Review. Biotechnol Bioeng 2017;114:260-80. [DOI: 10.1002/bit.26075] [Cited by in Crossref: 40] [Cited by in F6Publishing: 283] [Article Influence: 6.7] [Reference Citation Analysis]
27 Nicolay NH, Lopez Perez R, Saffrich R, Huber PE. Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic. Oncotarget 2015;6:19366-80. [PMID: 26203772 DOI: 10.18632/oncotarget.4358] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
28 Huh SW, Shetty AA, Ahmed S, Lee DH, Kim SJ. Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC). J Clin Orthop Trauma 2016;7:153-6. [PMID: 27489409 DOI: 10.1016/j.jcot.2016.05.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
29 Nicolay NH, Lopez Perez R, Rühle A, Trinh T, Sisombath S, Weber KJ, Ho AD, Debus J, Saffrich R, Huber PE. Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin. Sci Rep 2016;6:20035. [PMID: 26805490 DOI: 10.1038/srep20035] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
30 Siciliano C, Chimenti I, Bordin A, Ponti D, Iudicone P, Peruzzi M, Rendina EA, Calogero A, Pierelli L, Ibrahim M, De Falco E. The potential of GMP-compliant platelet lysate to induce a permissive state for cardiovascular transdifferentiation in human mediastinal adipose tissue-derived mesenchymal stem cells. Biomed Res Int 2015;2015:162439. [PMID: 26495284 DOI: 10.1155/2015/162439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
31 Nicolay NH, Lopez Perez R, Debus J, Huber PE. Mesenchymal stem cells – A new hope for radiotherapy-induced tissue damage? Cancer Letters 2015;366:133-40. [DOI: 10.1016/j.canlet.2015.06.012] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 9.6] [Reference Citation Analysis]
32 Zhang Y, Liang X, Liao S, Wang W, Wang J, Li X, Ding Y, Liang Y, Gao F, Yang M, Fu Q, Xu A, Chai YH, He J, Tse HF, Lian Q. Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy. Sci Rep 2015;5:11235. [PMID: 26057572 DOI: 10.1038/srep11235] [Cited by in Crossref: 69] [Cited by in F6Publishing: 76] [Article Influence: 9.9] [Reference Citation Analysis]
33 Liang X, Ding Y, Zhang Y, Chai YH, He J, Chiu SM, Gao F, Tse HF, Lian Q. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis. 2015;6:e1765. [PMID: 25996292 DOI: 10.1038/cddis.2015.91] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
34 Somanna NK, Wörner PM, Murthy SN, Pankey EA, Schächtele DJ, St Hilaire RC, Jansen D, Chaffin AE, Nossaman BD, Alt EU, Kadowitz PJ, Izadpanah R. Intratracheal administration of cyclooxygenase-1-transduced adipose tissue-derived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 2014;307:H1187-95. [PMID: 25320332 DOI: 10.1152/ajpheart.00589.2013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
35 Chachques JC, Pradas MM, Bayes-Genis A, Semino C. Creating the bioartificial myocardium for cardiac repair: challenges and clinical targets. Expert Rev Cardiovasc Ther 2013;11:1701-11. [PMID: 24215199 DOI: 10.1586/14779072.2013.854165] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
36 Shetty AA, Kim SJ, Shetty V, Stelzeneder D, Shetty N, Bilagi P, Lee H. Autologous bone-marrow mesenchymal cell induced chondrogenesis: Single-stage arthroscopic cartilage repair. Tissue Eng Regen Med 2014;11:247-53. [DOI: 10.1007/s13770-014-0061-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
37 Lu DF, Wang Y, Su ZZ, Zeng ZH, Xing XW, He ZY, Zhang C. Knockdown of the HDAC1 promotes the directed differentiation of bone mesenchymal stem cells into cardiomyocytes. PLoS One. 2014;9:e92179. [PMID: 24686813 DOI: 10.1371/journal.pone.0092179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
38 Kamarul T. Advances in stem cells technologies and their commercialization potential. Expert Review of Clinical Pharmacology 2014;6:363-5. [DOI: 10.1586/17512433.2013.811804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Lazzarini R, Olivieri F, Ferretti C, Mattioli-belmonte M, Di Primio R, Orciani M. mRNAs and miRNAs profiling of mesenchymal stem cells derived from amniotic fluid and skin: the double face of the coin. Cell Tissue Res 2014;355:121-30. [DOI: 10.1007/s00441-013-1725-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
40 Kumagai G, Tsoulfas P, Toh S, McNiece I, Bramlett HM, Dietrich WD. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol 2013;248:369-80. [PMID: 23856436 DOI: 10.1016/j.expneurol.2013.06.028] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]